Cargando…

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

BACKGROUND: Changes in promoter DNA methylation pattern of genes involved in key biological pathways have been reported in glioblastoma. Genome-wide assessments of DNA methylation levels are now required to decipher the epigenetic events involved in the aggressive phenotype of glioblastoma, and to g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etcheverry, Amandine, Aubry, Marc, de Tayrac, Marie, Vauleon, Elodie, Boniface, Rachel, Guenot, Frederique, Saikali, Stephan, Hamlat, Abderrahmane, Riffaud, Laurent, Menei, Philippe, Quillien, Veronique, Mosser, Jean
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018478/ https://www.ncbi.nlm.nih.gov/pubmed/21156036 http://dx.doi.org/10.1186/1471-2164-11-701

Ejemplares similares

Immune genes are associated with human glioblastoma pathology and patient survival
por: Vauléon, Elodie, et al.
Publicado: (2012)

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
por: Etcheverry, Amandine, et al.
Publicado: (2014)

‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2015)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach
por: Collet, Brigitte, et al.
Publicado: (2011)

Prognostic Significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, Four New Markers in High-Grade Gliomas
por: de Tayrac, Marie, et al.
Publicado: (2013)

The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line
por: Monnier, Annabelle, et al.
Publicado: (2018)

Overview of Cellular Immunotherapy for Patients with Glioblastoma
por: Vauleon, Elodie, et al.
Publicado: (2010)

Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link
por: Lemée, Jean-Michel, et al.
Publicado: (2018)

A five‐CpG signature of microRNA methylation in non‐G‐CIMP glioblastoma
por: Kang, En‐Ming, et al.
Publicado: (2019)

A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
por: Li, Bowen, et al.
Publicado: (2022)

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2019)

Dual IRE1 RNase functions dictate glioblastoma development
por: Lhomond, Stéphanie, et al.
Publicado: (2018)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas
por: Yin, Anan, et al.
Publicado: (2021)

Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
por: Yin, An-An, et al.
Publicado: (2019)

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme
por: Cheray, Mathilde, et al.
Publicado: (2020)

Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas
por: Yin, Anan, et al.
Publicado: (2017)

Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach
por: de Tayrac, Marie, et al.
Publicado: (2009)

Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome
por: Le Reste, Pierre‐Jean, et al.
Publicado: (2021)

Combining evidence, biomedical literature and statistical dependence: new insights for functional annotation of gene sets
por: Aubry, Marc, et al.
Publicado: (2006)

Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018)

EMT is associated with an epigenetic signature of ECM remodeling genes
por: Peixoto, Paul, et al.
Publicado: (2019)

ImmunoFISH Is a Reliable Technique for the Assessment of 1p and 19q Status in Oligodendrogliomas
por: Duval, Céline, et al.
Publicado: (2014)

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
por: Quillien, Véronique, et al.
Publicado: (2016)

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
por: Lachat, Camille, et al.
Publicado: (2020)

Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
por: Clavreul, Anne, et al.
Publicado: (2017)

Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas
por: Michaud, Karine, et al.
Publicado: (2018)

Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm
por: Duval, Céline, et al.
Publicado: (2015)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul, Anne, et al.
Publicado: (2015)

Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
por: Clavreul, Anne, et al.
Publicado: (2022)

Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines
por: Michaud, Karine, et al.
Publicado: (2016)

Incidence and Mortality of Spontaneous Subarachnoid Hemorrhage in Martinique
por: Schertz, Mathieu, et al.
Publicado: (2016)

RNA-sequencing of IDH-wild-type glioblastoma with chromothripsis identifies novel gene fusions with potential oncogenic properties
por: Ah-Pine, Franck, et al.
Publicado: (2020)

Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
por: Boisselier, Blandine, et al.
Publicado: (2018)

A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
por: Clavreul, Anne, et al.
Publicado: (2021)

The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2019)

Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2020)

Methylation analysis of the glypican 3 gene in embryonal tumours
por: Boily, G, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_cuq405euq4g3sj2kd9eqqkvmao